Literature DB >> 21840765

Survivors and nonsurvivors of very prolonged status epilepticus.

Frank W Drislane1, M Raquel Lopez, Andrew S Blum, Donald L Schomer.   

Abstract

Several studies have shown reliable predictive factors for outcome in status epilepticus (SE), especially etiology and presentation in coma. Duration of SE is predictive, but probably only in the first few hours, and there have been many reports of patients treated successfully for SE lasting many days or weeks. Nevertheless, there are many other patients with SE treated for prolonged periods without success, sometimes apparently futilely. We compared clinical features of 10 survivors of prolonged SE with those of a matched cohort treated for similarly prolonged episodes but unsuccessfully, looking for exceptions to known predictive factors. Multiple medical problems (i.e., etiologies) and coma on presentation were confirmed as predictors of a poor outcome. Analysis of individual exceptions to these predictors showed that age, overall background health, and family input on the value of prolonged treatment, on the one hand, and earlier epilepsy plus rapid and accurate diagnosis and treatment, on the other, contributed to results different from what would have been expected.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21840765     DOI: 10.1016/j.yebeh.2011.07.013

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  5 in total

1.  Electroclinical progression of subtle generalized convulsive status epilepticus: description of a case.

Authors:  José L Fernández-Torre; Eloy Rodríguez-Rodríguez; José L Vázquez-Higuera; Miguel A Hernández-Hernández
Journal:  J Neurol       Date:  2013-10-23       Impact factor: 4.849

2.  Clinical outcomes following prolonged refractory status epilepticus (PRSE).

Authors:  R D Kilbride; A S Reynolds; J P Szaflarski; L J Hirsch
Journal:  Neurocrit Care       Date:  2013-06       Impact factor: 3.210

Review 3.  Treatment of Refractory and Super-refractory Status Epilepticus.

Authors:  Samhitha Rai; Frank W Drislane
Journal:  Neurotherapeutics       Date:  2018-07       Impact factor: 7.620

4.  Acute Non-Convulsive Status Epilepticus after Experimental Traumatic Brain Injury in Rats.

Authors:  Pedro Andrade; Ivette Banuelos-Cabrera; Niina Lapinlampi; Tomi Paananen; Robert Ciszek; Xavier Ekolle Ndode-Ekane; Asla Pitkänen
Journal:  J Neurotrauma       Date:  2019-02-25       Impact factor: 5.269

Review 5.  Efficacy of topiramate as an add-on therapy in patients with refractory status epilepticus: a short systematic review.

Authors:  Leonardo Christiaan Welling; Nícollas Nunes Rabelo; Marcia Harumy Yoshikawa; João Paulo Mota Telles; Manoel Jacobsen Teixeira; Eberval Gadelha Figueiredo
Journal:  Rev Bras Ter Intensiva       Date:  2021-10-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.